中文别名 |
托氟沙星;对甲苯磺酸妥舒沙星;甲苯磺酸妥舒沙星;妥氟沙星;(+)-7-(3-氨基-1-吡咯烷基)-6-氟-1-(2,4-二氟苯基)-1,4-二氢-4-氧代-1,8-萘啶-3-羧酸;(11BS)-(-)-4,4-二丁基-2,6-双[3,5-双(三氟甲基)苯基]-4,5-二氢-3H-二萘并〔2,1-c:1,2-E]溴化膦;(11BS)-(-)-4,4-二丁基-2,6-双[3,5-双(三氟甲基)苯基]-4,5-二氢-3H-二萘并〔2,1-c:1'',2''-E]溴化膦;妥舒氟哌酸;托弗沙星 |
英文别名 |
1,8-Naphthyridine-3-carboxylicacid,7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-;1,8-Naphthyridine-3-carboxylicacid,7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-...;TOSUFLOXACIN TOSILATE;TOSUFLOXACIN TOSYLATE;Ozex;TETRAETHYL AMMONIUM IODIDE;TFLX;Toskisasin;TOSUFLOXACIN;TOSUFLOXACIN, ANTIBIOTIC FOR CULTURE MEDIA USE ONLY;Tosufloxacin p-toluenesulfonate;DTXSID2044135;HY-B1802;A-67107;NCGC00167536-02;AC-3509;A 61827;NCGC00167536-01;TOSUFLOXACIN [MI];7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid;Tosufloxacin;100490-36-6;TOSUFLOXACIN [MART.];( inverted exclamation markA)-7-(3-Amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic aci;FT-0696994;NS00011866;D02317;Q3995932;CHEBI:77581;1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, 7-(3-AMINO-1-PYRROLIDINYL)-1-(2,4-DIFLUOROPHENYL)-6-FLUORO-1,4-DIHYDRO-4-OXO-, (+/-)-;CHEMBL273348;TOSUFLOXACIN [INN];TOSUFLOXACIN [WHO-DD];100490-36-6;RKL10085;CS-0013843;EN300-19766363;()-7-(3-Amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic aci;(+/-)-7-(3-AMINO-1-PYRROLIDINYL)-1-(2,4-DIFLUOROPHENYL)-6-FLUORO-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID;A 67107;Z2681892005;7-(3-Amino-1-pyrrolidinyl-1-(2,4-diflurophenyl)-6-fluro-1,4-dihydro-4-oxo-naphthyridine-3-carboxylic acid;7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-;Tosufloxacin [USAN:INN];BDBM50230834;AB00698260-14;AB00698260-12;AKOS015960741;1,8-Naphthyridine-3-carboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-;Abbott-61827;CCRIS 6304;SCHEMBL34354;UNII-GHJ553KQPS;100490-36-6 (free base);7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylicacid;TOSUFLOXACIN [USAN];7-(3-Amino-pyrrolidin-1-yl)-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid;BCP12643;HMS2090B18;T-3262;GHJ553KQPS;108138-46-1;Abbott 61827;BRN 4913117;A-61827;SR-01000763339;GTPL12878;FT-0631007;SR-01000763339-3;Tosufloxacin 100 microg/mL in Acetonitrile;Tosufloxacin (USAN);7-(3-aminopyrrolin-1-yl)-1-(2,4-diflurophenyl)-1.4-dihydro-6-fluoro-4-oxo-1,8-napthyridine-3-carboxylic acid;tosufloxacinum;(RS)-tosufloxacin;TOSUFLOXACIN (MART.);racemic tosufloxacin;A 60969;A-64730;BRD-A41450521-003-02-7;T 3262;tosufloxacino;(+-)-tosufloxacin;CHEBI:77573;rac-tosufloxacin;DTXCID0024135;tosufloxacine;J01MA22;TS-09981;rac-7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid;BRD-A41450521-075-10-8;7-(3-amino-1-pyrrolidinyl)-1-(2,4-difl... |